|
Indication
|
Smears for this indication, among all smears performed (%)
|
Smears with added clinical value, among smears performed for this indication (%)
|
|---|
|
Any
|
515 (100%)
|
118 (23%)
|
|
Any RBC abnormality
|
259 (50%)
|
48 (19%)a
|
|
Any WBC cell abnormality
|
126 (24%)
|
32 (25%)a
|
|
Any PLT abnormality
|
150 (29%)
|
20 (13%)a
|
|
Any cytosis
|
53 (10%)
|
18 (34%)
|
|
Erythrocytosis
|
2 (0%)
|
0 (0%)
|
|
Leukocytosis
|
42 (8%)
|
18 (43%)
|
|
Thrombocytosis
|
12 (2%)
|
1 (8%)
|
|
Any cytopenia
|
267 (52%)
|
45 (17%)
|
|
Anemia
|
179 (35%)
|
32 (18%)
|
|
Leukopenia
|
79 (15%)
|
11 (14%)
|
|
Thrombocytopenia
|
135 (26%)
|
18 (13%)
|
|
Any abnormal cell morphology
|
39 (8%)
|
9 (23%)
|
|
RBC morphology
|
22 (4%)
|
4 (18%)
|
|
WBC morphology
|
6 (1%)
|
3 (50%)
|
|
PLT morphology
|
5 (1%)
|
1 (20%)
|
|
Hematolymphoid neoplasm
|
65 (13%)
|
30 (46%)
|
|
Blasts
|
5 (1%)
|
2 (40%)
|
|
Hemolysis
|
100 (19%)
|
24 (24%)
|
|
Parasites
|
4 (1%)
|
1 (25%)
|
|
Other
|
55 (11%)
|
15 (27%)
|
|
Not specified
|
33 (6%)
|
6 (18%)
|
- aThe proportion of smears with potential clinical value differed significantly across these three categories of indications (p = 0.0375)
- RBC Red blood cell, WBC White blood cell, PLT Platelet
